More than half of all human cancers have mutations that disable a protein called p53. When cells lose p53, tumors grow aggressively and often cannot be treated. But a new study by Alea Mills and colleagues from CSHL may offer a way to counteract the probl ...
Source:
Cold Spring Harbor Laboratory
Monday, November 9, 2009